U
U.S. Stem Cell, Inc. USRM
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Net Income 13.07% 9.39% 18.29% -5.13% -13.73%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.03% -2.36% -16.90% -10.27% -3.06%
Change in Net Operating Assets 914.95% 886.69% 150.14% 1,456.52% -80.04%
Cash from Operations 71.18% 50.27% 34.89% -14.62% -120.95%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -75.09% -76.68% -76.12% -88.50% 57.15%
Total Debt Repaid 47.02% -0.95% -13.91% -18.13% -10.15%
Issuance of Common Stock -69.09% 520.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -74.92% -47.52% -47.45% -66.40% 116.91%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -263.64% 99.80% -733.33% -203.92% 12.37%
Weiss Ratings